Close
Smartlab Europe
Inizio Ignite

Industry Reports

STA Pharmaceutical Sees Rapid Growth in MAH Programs in China

STA Pharmaceutical (STA) – a China-based global API and Drug Product CDMO – reports that it has seen a rapid uptake in companies with intent to market their products in China using it as a development and manufacturing partner...

Recipharm awarded for growth in France

Recipharm, a leading CDMO , has received recognition for its commitment to its French operations. The award “le Prix d’Excellence 2017 - Spécial Sciences de la vie” is presented by the Swedish Chamber of Commerce in France. ...

Celonic Acquires Glycotope’s Bio-manufacturing Facility

Celonic AG, a leading global biologics development and manufacturing services provider, and Glycotope, a clinical stage immune-oncology company, today announced the successful completion of Celonic’s acquisition of Glycotope’s bio-manufacturing facility in Heidelberg, Germany. The acquisition is...

CE Marking for World’s Only Integrated HIV Self-Test from Atomo Diagnostics Gives Access to Safe, Accurate and Reliable Self-Testing

Atomo Diagnostics, a world leader in innovative point-of-care, rapid diagnostic devices, announced today that its Atomo HIV Self Test has been granted CE Marking by a European Union Notified Body. The Atomo HIV Self Test is...

PCI Pharma Services to Acquire Millmount Healthcare

PCI Pharma Services is pleased to announce the acquisition of pharmaceutical and healthcare contract packaging services provider Millmount Healthcare, located near Dublin, Ireland. Millmount has been serving pharmaceutical and healthcare customers for over 20 years with...

A New International Conference On The Best Of Italian Track&Trace Technologies : The Marchesini Group And Sea Vision

On October 18th, the Marchesini Group, alongside SEA Vision - the Group’s longstanding Italian partner for vision systems for pharmaceutical and OEM industries - will be at the International Conference Industry 4.0: Trends in Pharma Manufacturing, Technologies & Packaging....

ABL acquisition extends Ardena’s early-phase offering

Early-phase contract development and manufacturing organisation (CDMO), Ardena, has acquired bioanalytical contract laboratory, Analytical Biochemical Laboratory (ABL). The acquisition of Netherlands-based ABL follows the merging of Pharmavize and Crystallics to form Ardena and broadens the CDMO’s...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »